Kotak Mahindra Asset Management Company Ltd • Equity
Kotak Pharma and Healthcare Investment Approach is an equity portfolio management service (PMS) strategy run by Kotak Mahindra Asset Management Company Ltd, launched on 20 Sep 2016. It manages ₹13.27 Cr of client assets and is benchmarked against the Nifty 500 TRI. Its reported trailing returns are +9.49% over 1 year, +20.03% over 3 years and +13.47% over 5 years (+12.14% since inception). The minimum investment is ₹50 Lakhs. The fund manager has not been publicly disclosed.
Last checked . Source: public PMS performance disclosures. Returns are as reported by the portfolio manager; past performance is not a guarantee of future returns.
| Period | Return |
|---|---|
| 1 Month | +6.87% |
| 3 Months | -2.75% |
| 1 Year | +9.49% |
| 3 Years | +20.03% |
| 5 Years | +13.47% |
| Since Inception | +12.14% |
A PMS needs at least ₹50 lakh. Before you commit, get a second opinion on fees, benchmark and fit from Foliyo, a fee-only SEBI Registered Investment Adviser.
Book an intro callKotak Pharma and Healthcare Investment Approach has a 1-year return of +9.49%, a 3-year return of +20.03%, a 5-year return of +13.47% and +12.14% since inception. Past performance is not indicative of future results.
Kotak Pharma and Healthcare Investment Approach manages ₹13.27 Cr of client assets.
The minimum investment for Kotak Pharma and Healthcare Investment Approach is ₹50 Lakhs.
Kotak Pharma and Healthcare Investment Approach was launched on 20 Sep 2016. It has a 9-year track record.
Description
All Kotak Mahindra PMS strategies →Browse all PMS strategies in India →